Unknown

Who we are

  • April 5, 2022
    First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
  • April 5, 2022
    Ipilimumab, Maraviroc and Nivolumab (LUMINESCENCE)
  • April 5, 2022
    A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
  • April 5, 2022
    Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer
  • April 5, 2022
    A study looking at using a vaccine and chemotherapy to treat advanced cancer
  • April 5, 2022
    Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
  • April 5, 2022
    The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer
  • April 5, 2022
    A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients
  • April 5, 2022
    Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer
  • April 5, 2022
    TAS102 in Combination With NAL-IRI in Advanced GI Cancers